TY - JOUR
T1 - Among respiratory symptoms, wheeze associates most strongly with impaired lung function in adults with asthma
T2 - A long-term prospective cohort study
AU - Bermúdez Barón, Nicolás
AU - Lindberg, Anne
AU - Stridsman, Caroline
AU - Andersson, Martin
AU - Hedman, Linnea
AU - Vikjord, Sigrid Anna
AU - Kankaanranta, Hannu
AU - Lundbäck, Bo
AU - Rönmark, Eva
AU - Backman, Helena
N1 - Funding Information:
Competing interests All authors have completed the ICMJE COI disclosure form. NBB has nothing to disclose. AL reports personal fees from Boehringer-Ingelheim, AstraZeneca, Novartis and GlaxoSmithKline outside the submitted work. CS reports personal fees from AstraZeneca, Boehringer-Ingelheim and Novartis outside the submitted work.MA has nothing to disclose. LH has nothing to disclose. SAV reports personal fees from AstraZeneca and Boehringer-Ingelheim outside the submitted work. HK reports personal fees and non-financial support from AstraZeneca, Boehringer-Ingelheim and Orion Pharma; personal fees from Chiesi Pharma AB, Novartis, Mundipharma, SanofiGenzyme and GlaxoSmithKline; outside of the submitted work.BL reports personal fees from Novartis and Sanofi; grants from AstraZeneca; outside the submitted work. ER has nothing to disclose. HB reports personal fees from AstraZeneca and Boehringer Ingelheim outside the submitted work.
Funding Information:
Funding Financial support was received from the Swedish Heart & Lung Foundation, the Swedish Research Council, the Nordic council, ALF – a regional agreement between Umeå University and Norrbotten County Council, Norrbotten County Council, the Swedish Asthma-Allergy Foundation, and Visare Norr.
Publisher Copyright:
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2021/7/19
Y1 - 2021/7/19
N2 - Background Asthma is a common disease and a major public health concern. Respiratory symptoms are related to its prognosis, which in turn associates with lung function. Still this association on a long-term basis is not entirely understood. Aim To study the association of the type and number of respiratory symptoms with FEV 1 and FEV 1 decline in women and men with asthma. Method A population-based cohort of adults with asthma was examined at study entry between 1986 and 2001 and at follow-up between 2012 and 2014, and n=977 had valid measurements of FEV 1 on both occasions. Data regarding respiratory symptoms at study entry (recurrent wheeze, dyspnoea, longstanding cough and productive cough) were analysed in relation to FEV 1 and annual decline in FEV 1, both unadjusted and adjusted for other potentially associated factors by linear regression. Results For both sexes recurrent wheeze and dyspnoea were associated with lower FEV 1 at study entry and follow-up, while productive cough was associated with lower FEV 1 only at follow-up. No associations were found between the type of symptoms and annual decline in FEV 1. In adjusted analyses, the association between recurrent wheeze and lower FEV 1 both at study entry and follow-up remained significant among women. Also, the association between a higher number of symptoms with lower FEV 1 both at study entry and follow-up were present for both sexes and remained after adjustment. Conclusions Particularly recurrent wheeze and a higher number of respiratory symptoms may predict lower lung function also in the long run among women and men with asthma.
AB - Background Asthma is a common disease and a major public health concern. Respiratory symptoms are related to its prognosis, which in turn associates with lung function. Still this association on a long-term basis is not entirely understood. Aim To study the association of the type and number of respiratory symptoms with FEV 1 and FEV 1 decline in women and men with asthma. Method A population-based cohort of adults with asthma was examined at study entry between 1986 and 2001 and at follow-up between 2012 and 2014, and n=977 had valid measurements of FEV 1 on both occasions. Data regarding respiratory symptoms at study entry (recurrent wheeze, dyspnoea, longstanding cough and productive cough) were analysed in relation to FEV 1 and annual decline in FEV 1, both unadjusted and adjusted for other potentially associated factors by linear regression. Results For both sexes recurrent wheeze and dyspnoea were associated with lower FEV 1 at study entry and follow-up, while productive cough was associated with lower FEV 1 only at follow-up. No associations were found between the type of symptoms and annual decline in FEV 1. In adjusted analyses, the association between recurrent wheeze and lower FEV 1 both at study entry and follow-up remained significant among women. Also, the association between a higher number of symptoms with lower FEV 1 both at study entry and follow-up were present for both sexes and remained after adjustment. Conclusions Particularly recurrent wheeze and a higher number of respiratory symptoms may predict lower lung function also in the long run among women and men with asthma.
KW - asthma epidemiology
KW - clinical epidemiology
U2 - 10.1136/bmjresp-2021-000981
DO - 10.1136/bmjresp-2021-000981
M3 - Article
AN - SCOPUS:85110821697
VL - 8
IS - 1
M1 - e000981
ER -